Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hofmann

Showing results (711-720 of 734) with videos related to

Pageof 74
Sort By:
Cell Metabolism|September 26, 2017
Molecular Integration of Incretin and Glucocorticoid Action Reverses Immunometabolic Dysfunction and ObesityCarmelo Quarta, Christoffer Clemmensen, Zhimeng Zhu, et al.
European Journal of Cancer (Oxford, England : 1990)|July 26, 2024
Prognostic impact of selection criteria of current adjuvant endocrine therapy trials NATALEE and monarchE in postmenopausal HRpos/HER2neg breast cancer patients treated with upfront letrozolePeter A Fasching, Carolin C Hack, Naiba Nabieva, et al.
Geburtshilfe Und Frauenheilkunde|February 12, 2024
Long-term Follow-up and Safety of Patients after an Upfront Therapy with Letrozole for Early Breast Cancer in Routine Clinical Care - The PreFace StudyCarolin C Hack, Nicolai Maass, Bahriye Aktas, et al.
The EMBO Journal|August 1, 2025
NRAC controls CD36-mediated fatty acid uptake in adipocytes and lipid clearance in vivoInderjeet Singh, Yasuhiro Onogi, Filipe Menezes, et al.
Nature Metabolism|August 22, 2022
GLP-1-mediated delivery of tesaglitazar improves obesity and glucose metabolism in male miceCarmelo Quarta, Kerstin Stemmer, Aaron Novikoff, et al.
International Journal of Cancer|July 11, 2025
Invasive disease-free and overall survival after (neo)adjuvant chemotherapy in postmenopausal patients with hormone receptor-positive, HER2-negative early breast cancer treated with upfront letrozole: Experiences from the phase IV PreFace trialMilena Beierlein, Lothar Häberle, Naiba Nabieva, et al.
Cell|October 11, 2016
Chemical Hybridization of Glucagon and Thyroid Hormone Optimizes Therapeutic Impact for Metabolic DiseaseBrian Finan, Christoffer Clemmensen, Zhimeng Zhu, et al.
Geburtshilfe Und Frauenheilkunde|May 1, 2024
Correction: Long-term Follow-up and Safety of Patients after an Upfront Therapy with Letrozole for Early Breast Cancer in Routine Clinical Care - The PreFace StudyCarolin C Hack, Nicolai Maass, Bahriye Aktas, et al.
Acta Crystallographica. Section B, Structural Science|March 21, 2009
Significant progress in predicting the crystal structures of small organic molecules--a report on the fourth blind testGraeme M Day, Timothy G Cooper, Aurora J Cruz-Cabeza, et al.
Acta Crystallographica. Section B, Structural Science|November 22, 2011
Towards crystal structure prediction of complex organic compounds--a report on the fifth blind testDavid A Bardwell, Claire S Adjiman, Yelena A Arnautova, et al.
Pageof 74

Showing results (711-720 of 734) with videos related to

Sort By:
Pageof 74
Cell Metabolism|September 26, 2017
Molecular Integration of Incretin and Glucocorticoid Action Reverses Immunometabolic Dysfunction and ObesityCarmelo Quarta, Christoffer Clemmensen, Zhimeng Zhu, et al.
European Journal of Cancer (Oxford, England : 1990)|July 26, 2024
Prognostic impact of selection criteria of current adjuvant endocrine therapy trials NATALEE and monarchE in postmenopausal HRpos/HER2neg breast cancer patients treated with upfront letrozolePeter A Fasching, Carolin C Hack, Naiba Nabieva, et al.
Geburtshilfe Und Frauenheilkunde|February 12, 2024
Long-term Follow-up and Safety of Patients after an Upfront Therapy with Letrozole for Early Breast Cancer in Routine Clinical Care - The PreFace StudyCarolin C Hack, Nicolai Maass, Bahriye Aktas, et al.
The EMBO Journal|August 1, 2025
NRAC controls CD36-mediated fatty acid uptake in adipocytes and lipid clearance in vivoInderjeet Singh, Yasuhiro Onogi, Filipe Menezes, et al.
Nature Metabolism|August 22, 2022
GLP-1-mediated delivery of tesaglitazar improves obesity and glucose metabolism in male miceCarmelo Quarta, Kerstin Stemmer, Aaron Novikoff, et al.
International Journal of Cancer|July 11, 2025
Invasive disease-free and overall survival after (neo)adjuvant chemotherapy in postmenopausal patients with hormone receptor-positive, HER2-negative early breast cancer treated with upfront letrozole: Experiences from the phase IV PreFace trialMilena Beierlein, Lothar Häberle, Naiba Nabieva, et al.
Cell|October 11, 2016
Chemical Hybridization of Glucagon and Thyroid Hormone Optimizes Therapeutic Impact for Metabolic DiseaseBrian Finan, Christoffer Clemmensen, Zhimeng Zhu, et al.
Geburtshilfe Und Frauenheilkunde|May 1, 2024
Correction: Long-term Follow-up and Safety of Patients after an Upfront Therapy with Letrozole for Early Breast Cancer in Routine Clinical Care - The PreFace StudyCarolin C Hack, Nicolai Maass, Bahriye Aktas, et al.
Acta Crystallographica. Section B, Structural Science|March 21, 2009
Significant progress in predicting the crystal structures of small organic molecules--a report on the fourth blind testGraeme M Day, Timothy G Cooper, Aurora J Cruz-Cabeza, et al.
Acta Crystallographica. Section B, Structural Science|November 22, 2011
Towards crystal structure prediction of complex organic compounds--a report on the fifth blind testDavid A Bardwell, Claire S Adjiman, Yelena A Arnautova, et al.
Pageof 74